The effects of chlorotrianisene (Tace) of kinetics of 3H-testosterone metabolism in patients with carcinoma of the prostate.

Alterations in the metabolism of testosterone and plasma levels of testosterone, luteinising hormone (LH), follicle stimulating hormone (FSH), prolactin and oestradiol were studied in 6 patients with newly diagnosed prostatic carcinoma before and during treatment with chlorotrianisene at a daily dosage of 48 mg for 14 days. Parameters of plasma kinetics were determined according to the single injection technique and the 2-compartment model, and the plasma hormones by radioimmunoassay. Chlorotrianisene altered neither plasma levels of testosterone, gonadotrophins, prolactin and oestradiol, nor metabolic clearance rate, production rate and other kinetic parameters of testosterone. Thus the beneficial effects which have been reported previously cannot be explained by suppression of peripheral testosterone metabolism.

[1]  G. Hutschenreiter,et al.  Kinetics of 3H-testosterone and 3H-dihydrotestosterone metabolism in patients with benign prostatic hypertrophy. Effect of cyproterone acetate. , 1977, European urology.

[2]  L. Srivastava,et al.  The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma. , 1976, The Journal of clinical endocrinology and metabolism.

[3]  H. Burger,et al.  The assessment of results following endocrine therapy for prostatic cancer. , 1975, The Journal of urology.

[4]  P. Knapstein,et al.  Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations. , 1975, Journal of steroid biochemistry.

[5]  J. D. Fergusson,et al.  Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. , 1973, British journal of urology.

[6]  H. Burger,et al.  EFFECTS OF SYNTHETIC ORAL OESTROGENS IN NORMAL MEN AND PATIENTS WITH PROSTATIC CARCINOMA: LACK OF GONADOTROPHIN SUPPRESSION BY CHLOROTRIANISENE , 1973, Clinical endocrinology.

[7]  R. Calandra,et al.  Kinetics of 3 H-testosterone metabolism in patients with carcinoma of the prostate: effects of oestrogen administration. , 1971, Acta endocrinologica.

[8]  R. N. Green,et al.  Effect of the administration of estrogen on the disappearance of 3H-testosterone in the plasma of human subjects. , 1969, The Journal of clinical endocrinology and metabolism.

[9]  V. Stevens,et al.  The effects of sex steroids on gonadotropins. , 1965, American journal of obstetrics and gynecology.

[10]  G. Calderini,et al.  [CONSIDERATIONS ON A NEW SYNTHETIC ESTROGEN IN THE THERAPY OF CARCINOMA OF THE PROSTATE (CHLOROTRIANISENE, TACE)]. , 1964, Minerva urologica.

[11]  B. Little,et al.  The disappearance of 7-H-3-d-aldosterone in the plasma of normal subjects. , 1961, The Journal of clinical investigation.

[12]  W. B. Kountz,et al.  THE ACTION OF CHLOROTRIANISENE (TACE) WITH ANDROGEN ON NITROGEN RETENTION IN ELDERLY PEOPLE , 1959, Journal of the American Geriatrics Society.

[13]  G. Carroll,et al.  TACE in the treatment of carcinoma of the prostate: an 80-month survey. , 1958, The Journal of urology.

[14]  G. Carroll,et al.  Endocrine therapy in carcinoma of the prostate. , 1955, Journal of the American Medical Association.

[15]  R. Hotchkiss,et al.  The role of the adrenal cortex in prostatic cancer. , 1955, The Journal of urology.

[16]  P. G. Smith,et al.  Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma. , 1951, The Journal of urology.

[17]  C. W. Emmens,et al.  OESTROGENS AND PRO-OESTROGENS RELATED TO STILBENE AND TRIPHENYLETHYLENE , 1942 .

[18]  C. W. Emmens,et al.  PRECURSORS OF OESTROGENS , 1940 .